Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year. These medications are "slated to make a big clinical ...

The FDA grants orphan status to medicines and biologics for rare diseases that meet certain criteria, opening the way for incentives such as accelerated approval and tax breaks to support their ...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...

Prior to Alyftrek’s approval, Vertex had previously brought four cystic fibrosis medicines to market, building a business that generated nearly $10 billion in 2023. Sales are expected to surpass that ...

When applied to your lash line on a daily basis, Latisse promotes the growth of lashes by extending the growth phase of the ...

Sleep apnea causes people to stop and start breathing repeatedly Zepbound is first drug approved by FDA to help treat it Two studies found that those who used it saw reduction in apnea events ...

If you struggle with thinning hair, here's what's causing it. Try one of these thinning hair treatments, including Rogaine, ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

This language likely means that the drug will be available only to diabetics, in contrast to some of the name-brand medications in this class which have been approved for some weight loss cases. The ...

In its second attempt, Takeda has secured FDA approval for Eohilia, which becomes the first and only oral therapy in the US for eosinophilic oesophagitis (EoE). The US regulator has cleared ...

An Eli Lilly & Co. Zepbound injection pen is arranged in the Brooklyn borough of New York March 28, 2024. (Getty Images) (NewsNation) — Zepbound became the first drug approved by the Food and Drug ...

Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's (MRK.N), opens new tab therapy to treat a rare lung condition, marking another ...